Literature DB >> 29112899

Authentication of animal origin of heparin and low molecular weight heparin including ovine, porcine and bovine species using 1D NMR spectroscopy and chemometric tools.

Yulia B Monakhova1, Bernd W K Diehl2, Jawed Fareed3.   

Abstract

High resolution (600MHz) nuclear magnetic resonance (NMR) spectroscopy is used to distinguish heparin and low-molecular weight heparins (LMWHs) produced from porcine, bovine and ovine mucosal tissues as well as their blends. For multivariate analysis several statistical methods such as principal component analysis (PCA), factor discriminant analysis (FDA), partial least squares - discriminant analysis (PLS-DA), linear discriminant analysis (LDA) were utilized for the modeling of NMR data of more than 100 authentic samples. Heparin and LMWH samples from the independent test set (n=15) were 100% correctly classified according to its animal origin. Moreover, by using 1H NMR coupled with chemometrics and several batches of bovine heparins from two producers were differentiated. Thus, NMR spectroscopy combined with chemometrics is an efficient tool for simultaneous identification of animal origin and process based manufacturing difference in heparin products.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  (1)H NMR spectroscopy; Animal origin; Authenticity; Chemometrics; Classification; Heparin; Manufacturer

Mesh:

Substances:

Year:  2017        PMID: 29112899     DOI: 10.1016/j.jpba.2017.10.020

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  7 in total

Review 1.  Advances in the preparation and synthesis of heparin and related products.

Authors:  Sultan N Baytas; Robert J Linhardt
Journal:  Drug Discov Today       Date:  2020-09-16       Impact factor: 7.851

2.  Novel Immunoassay for Complement Activation by PF4/Heparin Complexes.

Authors:  Sanjay Khandelwal; Alexandra M Johnson; Jian Liu; David Keire; Cynthia Sommers; Joann Ravi; Grace M Lee; John D Lambris; Edimara S Reis; Gowthami M Arepally
Journal:  Thromb Haemost       Date:  2018-06-30       Impact factor: 5.249

3.  Comparative Pharmacokinetic Profile of 3 Batches of Ovine Low-Molecular-Weight Heparin and 1 Batch of Branded Enoxaparin.

Authors:  Walter Jeske; Ahmed Kouta; Rick Duff; Varun Rangnekar; Manoj Niverthi; Debra Hoppensteadt; Jawed Fareed; Yiming Yao
Journal:  Clin Appl Thromb Hemost       Date:  2018-09-09       Impact factor: 2.389

Review 4.  Techniques for Detection of Clinical Used Heparins.

Authors:  Binjie Li; Huimin Zhao; Mingjia Yu
Journal:  Int J Anal Chem       Date:  2021-05-06       Impact factor: 1.885

5.  Bovine Mucosal Heparins Are Comparable to Porcine Mucosal Heparin at USP Potency Adjusted Levels.

Authors:  Walter Jeske; Ahmed Kouta; Ambar Farooqui; Fakiha Siddiqui; Varun Rangnekar; Manoj Niverthi; Rajan Laddu; Debra Hoppensteadt; Omer Iqbal; Jeanine Walenga; Jawed Fareed
Journal:  Front Med (Lausanne)       Date:  2019-01-09

6.  Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine Heparins.

Authors:  Ahmed Kouta; Walter Jeske; Debra Hoppensteadt; Omer Iqbal; Yiming Yao; Jawed Fareed
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

7.  Isolation and Characterization of a Heparin-Like Compound with Potent Anticoagulant and Fibrinolytic Activity from the Clam Coelomactra antiquata.

Authors:  ZhenXing Du; XueJing Jia; Jing Chen; SiYi Zhou; JianPing Chen; XiaoFei Liu; XiaoHuang Cao; SaiYi Zhong; PengZhi Hong
Journal:  Mar Drugs       Date:  2019-12-19       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.